Glucosamine oral bioavailability and plasma pharmacokinetics after increasing doses of crystalline glucosamine sulfate in man

Osteoarthritis and Cartilage

Volumn 13, Issue 12, 2005, Pages 1041-1049

  Persiani, Stefano ^a   Roda, E ^b   Rovati, L C ^a   Locatelli, M ^c   Giacovelli, G ^a   Roda, A ^c  

^a Rotta Research Laboratorium   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Bioavailability; Glucosamine sulfate; Human; Mechanism of action; Pharmacokinetics

Indexed keywords

GLUCOSAMINE; GLUCOSAMINE SULFATE; VIARTRIL S; XICIL;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG ELIMINATION; DRUG FORMULATION; DRUG HALF LIFE; DRUG MECHANISM; DRUG SAFETY; FEMALE; HUMAN; HUMAN EXPERIMENT; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; NORMAL HUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, ORAL; ADULT; ANALYSIS OF VARIANCE; BIOLOGICAL AVAILABILITY; CHROMATOGRAPHY, LIQUID; CROSS-OVER STUDIES; CRYSTALLIZATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; GLUCOSAMINE; HALF-LIFE; HUMANS; MALE; SPECTRUM ANALYSIS;

EID: 27944440047     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joca.2005.07.009     Document Type: Article

References (50)

1. T.E. McAlindon M.P. La Valley J.P. Gulin D.T. Felson Glucosamine and chondroitin for treatment of osteoarthritis: A systematic quality assessment and meta-analysis JAMA 283 2000 1469-1475
2. F. Richy O. Bruyere O. Ethgen M. Cucherat Y. Henrotin J.Y. Reginster Structural and symptomatic efficacy of glucosamine and chondroitin in knee osteoarthritis. A comprehensive meta-analysis Arch Intern Med 163 2003 1514-1522
3. Towheed TE, Maxwell L, Anastassiades TP, Shea B, Houpt J, Robinson V, et al. Glucosamine therapy for treating osteoarthritis. The Cochrane Database of Systematic Reviews 2005, Issue 2. Art. No.: CD002946. pub2. DOI: 10.1002/14651858. CD002946.
4. J.Y. Reginster R. Deroisy L.C. Rovati R.L. Lee E. Lejeune O. Bruyere Long-term effects of glucosamine sulfate on osteoarthritis progression: a randomised, placebo-controlled clinical trial Lancet 357 2001 251-256
5. K. Pavelka J. Gatterova M. Olejarova S. Machacek G. Giacovelli L.C. Rovati Glucosamine sulfate use and delay of progression of knee osteoarthritis: A 3-year, randomized, placebo-controlled, double-blind study Arch Intern Med 162 2002 2113-2123
6. K. Pavelka O. Bruyere L.C. Rovati M. Olejárova G. Giacovelli J.Y. Reginster Relief in mild-to-moderate pain is not a confounder in joint space narrowing assessment of full extension knee radiographs in recent osteoarthritis structure-modifying drug trials Osteoarthritis Cartilage 11 2003 730-737
7. O. Bruyere K. Pavelka L.C. Rovati R. Deroisy M. Olejarova J. Gatterova et al. Glucosamine sulfate reduces osteoarthritis progression in postmenopausal women with knee osteoarthritis: Evidence from two 3-year studies Menopause 11 2004 138-143
8. I. Setnikar L.C. Rovati Absorption, distribution, metabolism and excretion of glucosamine sulfate: A review Arzneimittelforschung 51 2001 699-725
9. T.A. Einhorn "If it feels good, do it" use of glucosamine sulfate to prevent the progression of osteoarthritis in postmenopausal women Menopause 11 2004 134-135
10. D. Hamerman The biology of osteoarthritis N Engl J Med 320 1989 1322-1330
11. Dietary Supplement Health and Education Act of 1994, Pub. L. No. 103-417, 103rd Congress; Oct 25, 1994.
12. A.S. Russell A. Aghazadeh-Habashi F. Jamali Active ingredient consistency of commercially available glucosamine sulfate products J Rheumatol 29 2002 2407-2409
13. J.B. Houpt R. McMillan C. Wein S.D. Paget-Dellio Effect of glucosamine hydrochloride in the treatment of pain of osteoarthritis of the knee J Rheumatol 26 1999 2423-2430
14. J.P. Rindone D. Hiller E. Collacott N. Nordhaugen G. Arriola Randomized, controlled trial of glucosamine for treating osteoarthritis of the knee West J Med 172 2000 91-94
15. R. Hughes A. Carr A randomized, double-blind, placebo-controlled trial of glucosamine sulphate as an analgesic in osteoarthritis of the knee Rheumatology 41 2002 279-284
16. J. Cibere J.A. Kopec A. Thorne J. Singer J. Canvin D.B. Robinson et al. Randomised, double-blind, placebo-controlled glucosamine discontinuation trial in knee osteoarthritis Arthritis Care Res 51 2004 738-745
17. T. McAlindon Why are clinical trials of glucosamine no longer uniformly positive? Rheum Dis Clin North Am 29 2003 789-801
18. I. Setnikar C. Giachetti G. Zanolo Pharmacokinetics of glucosamine in the dog and in man Arzneimittelforschung 36 1986 729-735
19. A. Aghazadeh-Habashi S. Settari F.M. Pasutto F. Jamali Single dose pharmacokinetics and bioavailability of glucosamine in the rat J Pharm Pharm Sci 5 2002 181-184
20. A. Adebowale J. Du Z. Liang J.L. Leslie N.D. Eddington The bioavailability and pharmacokinetics of glucosamine hydrochloride and low molecular weight chondroitin sulfate after single and multiple doses to beagle dogs Biopharm Drug Dispos 23 2002 217-235
21. J. Du N. White N.D. Eddington The bioavailability and pharmacokinetics of glucosamine hydrochloride and chondroitin sulfate after oral and intravenous single dose administration in the horse Biopharm Drug Dispos 25 2004 109-116
22. S. Laverty J.D. Sandy C. Celeste P. Vachon J.F. Marier A.H.K. Plaas Synovial fluid levels and serum pharmacokinetics in a large animal model following treatment with oral glucosamine at clinically relevant doses Arthritis Rheum 52 2005 181-191
23. Center for Drug Evaluation and Research Guidance for Industry on Bioavailability and Bioequivalence Studies for Orally Administered Drug Products-General Considerations 2003 US Food and Drug Administration Rockville, MD
24. B.J. Houston Kinetics of disposition of xenobiotics and their metabolites Drug Metabol Drug Interact 6 1988 47-83
25. S.-C. Chow J.-P. Liu Design and Analysis of Bioavailability and Bioequivalence Studies 2nd edn. 2000 Marcel Dekker New York, NY
26. M. Rowland T.N. Tozer Clinical Pharmacokinetics: Concepts and Application 3rd edn. 1995 Williams & Wilkins Philadelphia, PA
27. E.A. Noyszewski K. Wroblewski G.R. Dodge S. Kudchodkar J. Beers A.V. Sarma et al. Preferential incorporation of glucosamine into the galactosamine moieties of chondroitin sulfate in articular cartilage explants Arthritis Rheum 44 2001 1089-1095
28. C. Bassleer L.C. Rovati P. Franchimont Glucosamine sulfate stimulates proteoglycan production in human chondrocytes in vitro Osteoarthritis Cartilage 6 1998 427-434
29. M. Piperno P. Reboul M.P. Helio Le Graverand M.J. Peschard M. Annefeld M. Richard et al. Glucosamine sulfate modulates dysregulated activities of human osteoarthritic chondrocytes in vitro Osteoarthritis Cartilage 8 2000 207-212
30. G.R. Dodge S.A. Jimenez Glucosamine sulfate modulates the levels of aggrecan and matrix metalloproteinase-3 synthesized by cultured human osteoarthritis articular chondrocytes Osteoarthritis Cartilage 11 2003 424-432
31. J.D. Sandy D. Gamett V. Thompson C. Verscharen Chondrocyte-mediated catabolism of aggrecan: Aggreganase-dependent cleavage induced by interleukin-1 or retinoic acid can be inhibited by glucosamine Biochem J 335 1998 59-66
32. 35S-sulfate with cultured human chondrocytes to determine the effect of glucosamine concentration on formation of chondroitin sulfate Arthritis Rheum 50 2004 3574-3579
33. W. Noack M. Fischer K.K. Förster L.C. Rovati I. Setnikar Glucosamine sulfate in osteoarthritis of the knee Osteoarthritis Cartilage 2 1994 51-59
34. H. Müller-Faßbender G.L. Bach W. Haase L.C. Rovati I. Setnikar Glucosamine sulfate compared to ibuprofen in osteoarthritis of the knee Osteoarthritis Cartilage 2 1994 61-69
35. T. McAlindon Glucosamine for osteoarthritis: Dawn of a new era? Lancet 357 2001 247-248
36. K.M. Jordan N.K. Arden M. Doherty J.W.J. Bijlsma P. Dieppe K. Gunther et al. EULAR recommendations 2003: An evidence based approach to the management of knee osteoarthritis: Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT) Ann Rheum Dis 62 2003 1145-1155
37. J.N. Gouze K. Bordji S. Gulberti B. Terlain P. Netter J. Magdalou et al. Interleukin-1beta down-regulates the expression of glucuronosyltransferase I, a key enzyme priming glycosaminoglycan biosynthesis: Influence of glucosamine on interleukin-1beta-mediated effects in rat chondrocytes Arthritis Rheum 44 2001 351-360
38. A.R. Shikhman K. Kuhn N. Alaaeddine M. Lotz N-acetylglucosamine prevents IL-1 beta-mediated activation of human chondrocytes J Immunol 166 2001 5155-5160
39. J.N. Gouze A. Bianchi P. Becuwe M. Dauca P. Netter J. Magdalou et al. Glucosamine modulates IL-1-induced activation of rat chondrocytes at a receptor level, and by inhibiting the NF-kappa B pathway FEBS Lett 510 2002 166-170
40. R. Largo M.A. Alvarez-Soria I. Dìez-Ortego E. Calvo O. Sánchez-Pernaute J. Egido et al. Glucosamine inhibits IL-1β-induced NFκB activation in human osteoarthritic chondrocytes Osteoarthritis Cartilage 11 2003 290-298
41. O. Letari S. Colombo T. Zanelli T. Piepoli F. Makovec L.C. Rovati The mechanism of action of glucosamine sulfate in osteoarthritis: IL-1β-mediated reactive oxygen species generation and modulation of NK-kB pathway (Abstract) Arthritis Rheum 48 9 Suppl 2003 664
42. P.S. Chan J.P. Caron M.W. Orth Glucosamine and chondroitin sulfate regulate inflammatory mediators (Abstract) Osteoarthritis Cartilage 12 Suppl B 2004 P325
43. P.S. Chan J.P. Caron M.W. Orth Glucosamine and chondroitin sulfate regulate IL-1 induced gene expression (Abstract) Osteoarthritis Cartilage 12 Suppl B 2004 P326
44. G.R. Dodge R.R. Regatte J.O. Hall A. Borthakur A.V. Sarma D.A. Callaway et al. The fate of oral glucosamine sulfate traced by 13C-labelling in the dog (Abstract) Arthritis Rheum 44 9 Suppl 2001 1534
45. I. Giraud M. Rapp J.C. Maurizis J.C. Madelmont Application to a cartilage targeting strategy: Synthesis and in vivo biodistribution of (14)C-labeled quaternary ammonium-glucosamine conjugates Bioconjug Chem 11 2000 212-218
46. L.J. Hoffer L.N. Kaplan M.J. Hamadeh A.C. Grigoriu M. Baron Sulfate could mediate the therapeutic effect of glucosamine sulfate Metabolism 50 2001 767-770
47. F. Cordoba M.E. Nimni Chondroitin sulfate and other sulfate containing chondroprotective agents may exhibit their effects by overcoming a deficiency of sulphur amino acids Osteoarthritis Cartilage 11 2003 228-230
48. Shargel L, Yu ABC, editors. Pharmaceutic factors affecting drug bioavailability In: Applied biopharmaceutics and pharmacokinetics. 2nd edn. Norwark (CT): Appleton-Century-Crofts;1985. p. 74-78.
49. Glucosamine/Chondroitin Arthritis Intervention Trial Available from http://www.nihgait.org
50. De Wan M, Volpi G, inventors. A method of preparing mixed glucosamine salts. US patent 5,847,107; Aug 13, 1997.